PR PolyResearch

Join Free

NASDAQ

BillionToOne, Inc. - Class A (BLLN)

♥ 382 Thanks from members

BillionToOne, Inc. (BLLN) displays robust top-line growth driven by surging prenatal and oncology test volumes, though recent Q2 2026 earnings missed consensus estimates, triggering notable post-earnings stock volatility.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Other Nasdaq Tickers

GraniteShares 2x Long AAPL Daily ETF (AAPB)

Apple Inc. (AAPL)

Direxion Daily AAPL Bear 1X ETF (AAPD)

Ascentage Pharma Group International - American Depository Shares (AAPG)

Direxion Daily AAPL Bull 2X ETF (AAPU)

Rocket Pharmaceuticals, Inc. - Warrant (RCKTW)